Zenith Drugs IPO Details ( Zenith Drugs Limited IPO Review )
(19 Feb 2024 – 22 Feb 2024)
Established in the year 2000, Zenith Drugs Limited is a pharmaceutical company focused on producing and trading top-notch, affordable medicines, including generic drugs.
We strictly adhere to the guidelines set by the World Health Organization (WHO-GMP) and have earned the ISO 9001:2015 certification from a reputable EuroUK certification body, showcasing our dedication to maintaining high quality.
Our product range includes:
- ORS Powder
- Liquid Orals
- Ointments
- Liquid Externals
- Capsules
With approval from the Food & Drugs Administration, we currently have over 600 products, with 325 actively in production.
Excitingly, we’re in the process of establishing a new manufacturing facility in Village Muradpura, Depalpur, Indore, Madhya Pradesh.
We proudly supply our products to various countries, including Costa Rica in Central America, the Caribbean and Pacific regions, as well as Malawi, Mauritius, Mozambique, Sudan, Tanzania, Bhutan, Cambodia in Southeast Asia, Tajikistan, Liberia, Sierra Leone, and Conakry.
At Zenith Drugs Limited, we specialize in third-party manufacturing, also known as white label manufacturing, serving esteemed pharmaceutical companies like Ajanta Pharma, Bio Medical Laboratories, and Zest Pharma, among others.
As of March 31, 2023, our team consists of 89 employees, with 61 on payroll and 28 on contract.
Zenith Drugs Limited IPO Competitive Strength
- Experienced Promoters and Management Team
- Cost Efficiency
- Formulations & Development
- Regulatory Compliance
- Global Reach
- Product Portfolio
- Supply Chain Efficiency
- Scalable Business Model
- Strong sales, marketing, and distribution capabilities
Zenith Drugs IPO Financials Performance ( Results )
Zenith Drugs Limited Financial Information (Restated Consolidated)
All Amount in ₹ Lakhs
| Period Ended | Total Assets | Total Revenue | PAT | EPS (₹) | Net Worth | NAV (₹) | Reserves | Borrowing |
| 31-Mar-22 | 6,858.47 | 9,266.63 | 312.86 | 2.62 | 1,209.09 | 10.08 | 1,169.09 | 1,880.86 |
| 31-Mar-23 | 9,793.83 | 11,569.65 | 515.29 | 4.29 | 1,724.42 | 14.37 | 1,684.42 | 2,605.03 |
| 30-Sep-23 | 11,249.04 | 6,948.43 | 539.38 | 4.50 | 2,264.96 | 18.87 | 1,064.96 | 2,902.81 |
Objective of Zenith Drugs IPO Issue
- Purchase of Machinery & Equipments for Setting up New Unit
- Existing Manufacturing Block Upgradation
- Working Capital Requirements
- General Corporate Purposes.
Zenith Drugs IPO Basic Details
| IPO Date | Feb 19, 2024 to Feb 22, 2024 |
| Listing Date | Tuesday, February 27, 2024 |
| Face Value | ₹10 per share |
| Price | ₹75 to ₹79 per share |
| Lot Size | 1600 Shares |
| Issue Size | 5,148,800 shares of ₹10 (aggregating up to ₹40.68 Cr) |
| Fresh Issue | 5,148,800 shares of ₹10 (aggregating up to ₹40.68 Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | NSE SME |
| Share holding pre issue | 12,000,000 |
| Share holding post issue | 17,148,800 |
| Company Promoters | Mr. Sandeep Bhardwaj, Mr. Bhupesh Soni and Mr. Ajay Singh Dassundi |
Zenith Drugs IPO Reservation
| QIB Shares Offered | 50% of the Net Issue |
| NII (HNI) Shares Offered | 15% of the Net Issue |
| Retail Shares Offered | 35% of the Net Issue |
Zenith Drugs IPO Timetable
Zenith Drugs IPO will open on February 19, 2024 and close on February 22, 2024. You can join Zenith Drugs IPO at 10.00 A.M. to 5.00 p.m. Upto which mandate can be applied.
| Event | Date |
| Opening Date | 19 February 2024 (Monday) |
| Closing Date | 22 February 2024 (Thursday) |
| Basis of Allotment | 23 February 2024 (Friday) |
| Initiation of Refunds | 26 February 2024 (Monday) |
| Credit of Shares to Demat | 26 February 2024 (Monday) |
| Listing Date | 27 February 2024 (Tuesday) |
| Deadline for UPI mandate confirmation | 5 PM on 22 February 2024 |
Zenith Drugs IPO Lot Size
For retail investors in Zenith Drugs IPO, 1600 shares will come in 1 lot or the minimum investment will be ₹126,400. Retail-individual investors can apply for up to 1 lots or the maximum investment will be ₹126,400.
| Application | Lots | Shares | Amount |
| Retail (Min) | 1 | 1600 | ₹126,400 |
| Retail (Max) | 1 | 1600 | ₹126,400 |
| S-HNI (Min) | 2 | 3200 | ₹252,800 |
Zenith Drugs IPO Promoter Holding
The company’s promoters include Mr. Sandeep Bhardwaj, Mr. Bhupesh Soni and Mr. Ajay Singh Dassundi.
| Pre Issue Share Holding | 100.00% |
| Post Issue Share Holding | 69.98% |
Zenith Drugs Ltd IPO Key Performance Indicator ( Valuation )
In the table given below, all the figures have been told according to the latest financial year.
| KPI | Values |
| Market Cap (₹ Cr.) | 135.48 |
| Earning Per Share (EPS) | ₹4.29 per Equity Share |
| Net Asset Value (NAV) | ₹14.37 per Equity Share |
| P/E Ratio (P/E) (x) | 18.40 |
| Post P/E Ratio (P/E) (x) | 12.56 |
| Return on Net Worth (RoNW) (%) | 29.88 |
| Return on equity (ROE) (%) | 35.13 |
| Return on Capital Employed (ROCE) (%) | 37.29 |
| Debt/Equity Ratio | 1.51 |
| Price/Book Value Ratio | 5.50 |
Zenith Drugs Ltd Peer Comparison
| Company Name | Consolidated/ Standalone | CMP (₹) | Face Value | EPS (₹) | P/E Ratio | RoNW (%) |
| Zenith Drugs Limited | Consolidated | 79.00 | 10.00 | 4.29 | 18.40 | 29.88 |
| Peer Group | ||||||
| Sudarshan Pharma Industries Limited | Consolidated | 77.00 | 10.00 | 5.48 | 41.11 | 13.07 |
| Sigachi Industries Limited | Consolidated | 78.40 | 10.00 | 13.52 | 28.64 | 18.75 |
Zenith Drugs IPO GMP Live Update, Kostak Rate day by day
| Date | GMP | Kostak | Subject to |
| Today | ₹7 | – | – |
| 16 February 2024 | ₹7 | – | – |
| 15 February 2024 | ₹6 | – | – |
Zenith Drugs IPO Detail Video:
link
Zenith Drugs IPO Subscription Status (Bidding Detail)
The Zenith Drugs IPO on February 22, 2024 at 7:30:00 PM was subscribed 179.18 times, with the retail category being subscribed 139.28 times, the NII (Non-Institutional Investor) category being subscribed 368.77 times, QIB (Qualified-Institutional Buyers) category being subscribed 106.72 times.
| Category | Subscription |
| QIB | 106.72x |
| NII | 368.77x |
| Retail | 139.28x |
| Total | 179.18x |
Zenith Drugs IPO Prospectus
| Zenith Drugs IPO DRHP | Download |
| Zenith Drugs IPO RHP | Download |
| Zenith Drugs IPO Anchor Investors Details PDF | Download |
Zenith Drugs IPO Rating
| Our Rating | 2.0/5.0 |
Zenith Drugs Company Contact Information
Zenith Drugs Limited
Registered Office: K. No. 72/5, Village Muradpura, NA, Depalpur, Indore-453001, Madhya Pradesh, India.
Contact Person: Ms. Sakshi Bhawsar: Company Secretary and Compliance Officer
Email Id: info@zenithdrugs.com
Tel No: +91 8435501867
Website: www.zenithdrugs.com
Our Promoters: Mr. Sandeep Bhardwaj, Mr. Bhupesh Soni and Mr. Ajay Singh Dassundi
Zenith Drugs IPO Registrar
Bigshare Services Private Limited
Registered Office: S6-2, 6th Pinnacle Business Park, Mahakali Caves Road, next to Ahura Centre, Andheri East, Mumbai- 400093, Maharashtra, India
Tel No.: +91 – 22 – 6263 8200; Fax No.: +91 – 22 – 6263 8299
E-mail: ipo@bigshareonline.com
Investor Grievance E-mail: investor@bigshareonline.com
Website: www.bigshareonline.com
Contact Person: Mr. Asif Sayyed
SEBI Registration No.: INR000001385
Zenith Drugs IPO Lead Manager
Gretex Corporate Services Limited
Registered Office: Office No. 13, 1st Floor, New Bansilal Building, Raja Bahadur Mansion, 9-15, Homi Modi
Street, Fort, Mumbai– 400001, Maharashtra, India.
Tel No.: +91 96532 49863
Email: info@gretexgroup.com
Website: www.gretexcorporate.com
Contact Person: Ms. Dimple Magharam Slun
SEBI Registration No: INM000012177
CIN: L74999MH2008PLC288128
Zenith Drugs IPO FAQs
What is the lot size of Zenith Drugs IPO?
The total size of Zenith Drugs IPO is ₹40.68 crores and this is a complete fresh Issue.
When will Zenith Drugs IPO start?
Zenith Drugs IPO will open from 19 February 2024 and IPO will close on 22 February 2024.
What is the open date of Zenith Drugs IPO?
Zenith Drugs IPO will open date from 19 February 2024.
What is the last date ( close date ) of Zenith Drugs IPO?
Zenith Drugs IPO will close from 22 February 2024.
What is the price band of Zenith Drugs IPO?
Zenith Drugs IPO price band is ₹75 to ₹79. ( Upper Price Band: ₹79, Lower Price Band: ₹75 )
What is the minimum amount required to apply for Zenith Drugs IPO?
The minimum investment for retailers to apply for Zenith Drugs IPO is ₹126,400 and the maximum investment is ₹126,400.
What is going on gray market premium of Zenith Drugs IPO?
View gray market premium of Zenith Drugs IPO by Clicking Here
How much is the GMP of Zenith Drugs IPO?
Watch Zenith Drugs IPO GMP Today: Click Here
What is the allotment date of Zenith Drugs IPO?
The allotment date of Zenith Drugs IPO is 23 February 2024.
How to check allotment status in Zenith Drugs IPO?
To check the allotment status of Zenith Drugs IPO, first of all go to the registrar website by clicking here, select your bad Zenith Drugs IPO name or enter your bad application number, PAN number or client ID and click on submit. ( Video Link )
What is the listing date of Zenith Drugs IPO?
The listing date of Zenith Drugs IPO is 27 February 2024.
How much will be the listing gain in Zenith Drugs IPO?
View listing gain of Zenith Drugs IPO by Clicking Here
How much time Zenith Drugs IPO is subscribed?
Total 179.18 times subscribed in Zenith Drugs IPO out of which 139.28 times subscription was done in retail quota, 368.77 times subscription in NII quota and 106.72 times subscription in QIB quota.
How to apply for Zenith Drugs IPO from Upstox?
Click Here to see how to apply for Zenith Drugs IPO from Upstox. (step by step)
How to apply for Zenith Drugs PO from Zerodha?
Click Here to see how to apply for Zenith Drugs IPO from Zerodha. (step by step)
How to apply for Zenith Drugs IPO from Angle One?
Click Here to see how to apply for Zenith Drugs IPO from Angle One. (step by step)
